12 March 2015 - Deborah Wilkes
Archived
Mexico's Genomma Lab has implemented a new commercial strategy in its domestic OTC market, and plans to sell the Marzam distribution company acquired in 2014. The news comes soon after Genomma reported that its Mexican sales had dropped by 43.4% to MXN1.42 billion (US$92 million) in the fourth quarter of 2014.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.